Shares of Waters Co. (NYSE:WAT – Get Rating) have earned a consensus suggestion of “Maintain” from the eleven analysts which might be presently masking the agency, Marketbeat Ratings experiences. Six equities analysis analysts have rated the inventory with a maintain suggestion and two have issued a purchase suggestion on the corporate. The common 1-year value goal amongst brokers which have up to date their protection on the inventory within the final 12 months is $341.67.
WAT has been the topic of various analysis analyst experiences. Barclays lowered their value goal on shares of Waters from $345.00 to $340.00 and set an “obese” ranking for the corporate in a analysis report on Thursday, October sixth. Robert W. Baird dropped their value goal on Waters from $348.00 to $317.00 in a analysis be aware on Wednesday, November 2nd. Deutsche Financial institution Aktiengesellschaft started protection on Waters in a report on Tuesday, December thirteenth. They issued a “maintain” ranking and a $350.00 goal value for the corporate. StockNews.com began protection on Waters in a analysis be aware on Wednesday, October twelfth. They set a “purchase” ranking on the inventory. Lastly, SVB Leerink upped their value goal on Waters from $310.00 to $320.00 and gave the corporate a “market carry out” ranking in a analysis be aware on Wednesday, November 2nd.
Waters Inventory Efficiency
Shares of Waters stock opened at $346.66 on Friday. The corporate has a 50 day shifting common of $322.09 and a 200-day shifting common of $318.04. The corporate has a market cap of $20.59 billion, a PE ratio of 30.25, a price-to-earnings-growth ratio of 4.02 and a beta of 0.93. Waters has a 1-year low of $265.61 and a 1-year excessive of $375.24. The corporate has a present ratio of two.15, a fast ratio of 1.55 and a debt-to-equity ratio of three.88.
Waters (NYSE:WAT – Get Rating) final launched its quarterly earnings information on Tuesday, November 1st. The medical devices provider reported $2.64 earnings per share for the quarter, beating the consensus estimate of $2.57 by $0.07. The enterprise had income of $708.56 million for the quarter, in comparison with analyst estimates of $680.30 million. Waters had a return on fairness of 189.79% and a internet margin of 23.63%. As a bunch, equities analysis analysts forecast that Waters will put up 11.92 earnings per share for the present fiscal 12 months.
Insider Transactions at Waters
In different Waters information, Director Edward Conard offered 1,059 shares of the inventory in a transaction that occurred on Wednesday, November thirtieth. The shares had been offered at a mean value of $334.70, for a complete transaction of $354,447.30. Following the completion of the sale, the director now owns 74,224 shares of the corporate’s inventory, valued at roughly $24,842,772.80. The transaction was disclosed in a authorized submitting with the Securities & Change Fee, which is accessible via the SEC website. 0.77% of the inventory is owned by company insiders.
Institutional Buying and selling of Waters
A lot of institutional traders have just lately purchased and offered shares of WAT. Asset Dedication LLC purchased a brand new stake in shares of Waters through the third quarter valued at about $26,000. EdgeRock Capital LLC purchased a brand new place in shares of Waters through the third quarter value roughly $27,000. Guardian Wealth Advisors LLC acquired a brand new stake in shares of Waters through the third quarter value roughly $31,000. Clear Road Markets LLC elevated its stake in shares of Waters by 404.0% within the 2nd quarter. Clear Road Markets LLC now owns 126 shares of the medical devices provider’s inventory valued at $42,000 after buying an extra 101 shares within the final quarter. Lastly, CI Investments Inc. lifted its place in shares of Waters by 75.5% through the third quarter. CI Investments Inc. now owns 165 shares of the medical devices provider’s inventory valued at $44,000 after buying an extra 71 shares through the interval. Institutional traders personal 88.58% of the corporate’s inventory.
Waters Firm Profile
Waters Company, a specialty measurement firm, offers analytical workflow options in Asia, the Americas, and Europe. It operates via two segments, Waters and TA. The corporate designs, manufactures, sells, and providers excessive and ultra-performance liquid chromatography, in addition to mass spectrometry (MS) know-how programs and help merchandise, together with chromatography columns, different consumable merchandise, and post-warranty service plans.
This instantaneous information alert was generated by narrative science know-how and monetary information from MarketBeat so as to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to firstname.lastname@example.org.
Earlier than you contemplate Waters, you will wish to hear this.
MarketBeat retains observe of Wall Road’s top-rated and finest performing analysis analysts and the shares they suggest to their shoppers each day. MarketBeat has recognized the five stocks that prime analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and Waters wasn’t on the record.
Whereas Waters at present has a “Maintain” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.